Sachin Madhukar Kadoo

Affiliation : Shreya Life Sciences Pvt. Ltd., Mumbai, India

Profile ID : RP-000-7265

Date : 2023-03-09

Articles List : 1

Social Share

Articles List

A prospective, post-marketing surveillance (PMS) study to monitor the safety of fixed dose combination of Triprolidine Hydrochloride IP 2.5 mg and Phenylephrine Hydrochloride IP 5 mg [Recofast Tablets] for the symptomatic relief in patients with uppe

Authors : Sachin Madhukar Kadoo, Preksha Pramod Patil

DOI : 10.18231/j.ijpp.2023.010